Customized Apple® iPad AirTM Enhances Doctor-Patient Interactions in Clinical Trials
Matthew Stumm, principal, BBK Worldwide (BBK), has been named by PharmaVOICE magazine as one of the 100 most inspiring individuals throughout the life-sciences industry. Recognized as a leading “change agent,” Stumm is credited with revolutionizing traditional patient recruitment tactics. Stumm has been instrumental in forging BBK’s milestones of innovation, including leveraging Google virtual tours for patient and site engagement. More recently, he led an industry-wide dialogue about mobile technologies and the role apps play in healthcare awareness.
Agency Engages Untapped Audiences and Provides Clinical Trial Sponsors With Increased Return on Investment
Imagine doubling the size of a football field and the teams that play on it. Bigger territory and more players might require a reorganization of responsibilities on the field. Suddenly, it’s a new game. Players who once held supporting roles might find themselves in key positions accountable for scoring. But will their talents be a natural fit for the new job? Some will and some won’t. It makes sense. A similar scenario is playing out in the clinical research industry. The proliferation of multinational studies has broadened the clinical research playing field, bringing accountability for “scoring” up the chain. Country study managers (CSMs), responsible for the success of a protocol within their country, are now accountable for more complex and strategic activities, including patient enrollment — the clinical study equivalent to scoring.
In an industry increasingly defined by mergers and acquisitions, BBK Worldwide (BBK) is bucking the trend by creating ownership opportunities from within. Celebrating 30 years, BBK remains one of the only independent and self-funded patient recruitment agencies, and is able to offer its global pharmaceutical and medical device clients levels of flexibility and creative innovation unmatched by its competitors. This history of vision and leadership has led BBK to name four additional principals who, together, will assume a minority ownership in the company. All long-serving employees, Matthew Kibby, Rob Laurens, Liz Ritchie, and Matthew Stumm have played key roles in shaping the company's success as the global leader in patient recruitment for the clinical R&D segment of the pharma, biotech, and medical device industries. As principals, they will partner with BBK's founding principals Joan F. Bachenheimer and Bonnie A. Brescia to maintain the company's core mission and values while driving growth in key market areas.
Topics: BBK Worldwide
BBK Worldwide announced today an expanded suite of products that streamlines retention efforts at the site level. Among these products are the Ready. Set. Go.℠ Card (RSG℠ Card), Ready. Set. Go.℠ Ride (RSG℠ Ride), and Ready. Set. Go.℠ Minder (RSG℠ Minder). These products are customized for today’s clinical research coordinator who is tasked with multiple responsibilities and demands. Through the efficiencies these products create, the clinical research coordinator is allowed to focus his or her efforts on other study-related priorities.
The holidays are upon us and once again our world is alight with bright advertisements promising eternal familial peace (but only if we can just get our shopping completed on time). With consumer attention turned to the tantalizing splurges, where does that leave campaigns marketing clinical trials? Many clients question whether to forgo or delay their media campaign during the holiday season; citing fears such as a site’s ability to manage referrals on limited schedules and financial value when the campaign is competing for attention against consumer goods. While referral numbers and office visits may be lower than the norm, it’s important to remember that many holiday-goers do have health plans on the horizon for themselves and their families…tomorrow.
If you haven’t figured out already, BBK looooooooves metrics. It’s something we often talk about in our blog (Real-Time Enrollment Data, Right Now). Oh and let’s not forget, the development of our patient recruitment management system, TrialCentralNet(SM). That all being said, we are excited to continue our campaign for the importance of metrics. Next stop? Allan Lloyd’s Patient Recruitment and Retention Summit in Chicago, October 23rd-25th.